Gut Health & Microbiome - IBS & symptoms
IBS: symptoms, diagnosis and treatment
Last updated 30 September 2026. How we write this.
IBS involves recurring abdominal pain and altered bowel habits. Diagnosis uses symptom patterns and targeted checks; management depends on symptoms, preferences and evidence.
Irritable bowel syndrome, or IBS, involves recurring abdominal pain alongside changes in bowel habits, without visible structural disease explaining the symptoms. Diagnosis combines a recognisable symptom pattern with assessment for other possible causes, rather than relying on a single definitive test. Management is individual and can include selected dietary changes, soluble fibre, gut-directed psychological approaches and medicines matched to particular symptoms.
What IBS is, and what it feels like
IBS is described as a disorder of gut-brain interaction. This means that bowel function, gut sensation and the nervous system's processing of digestive signals interact differently. Symptoms are real even when routine investigations show no obvious damage: a normal-looking bowel does not necessarily function or feel normal.
Abdominal pain typically relates to passing stool or accompanies a change in stool frequency or form. Pain may improve after a bowel movement, but it can also worsen. Bloating, urgency, straining and a feeling of incomplete emptying are common accompanying features. Bloating alone, however, is not enough to establish IBS.
Clinicians distinguish constipation-predominant IBS, diarrhoea-predominant IBS and a mixed pattern. These categories describe bowel habits rather than separate underlying diseases, and a person's pattern can change. Symptoms often fluctuate, so a difficult week does not necessarily mean progressive damage, while an easier week does not invalidate earlier difficulties.
How the gut and brain generate symptoms
The bowel continually moves its contents through coordinated muscle contractions. Changes in movement and fluid handling can produce harder stools, loose stools or urgency. Meanwhile, sensory nerves report stretching and chemical changes to the nervous system. In some people with IBS, ordinary stretching produces unusually strong discomfort, a phenomenon called visceral hypersensitivity.
Communication runs in both directions. Gut signals influence attention and emotion, while brain and autonomic nervous system activity influence bowel movement and pain processing. Stress can amplify symptoms, but it is neither necessary for IBS nor proof of its cause. Anxiety can also develop because unpredictable symptoms disrupt daily life.
Food can affect this system through several mechanisms. Some carbohydrates draw water into the bowel and are fermented by microbes, producing gas. The resulting stretch may be uncomfortable in a sensitive gut. A symptom response therefore does not automatically establish food allergy, tissue injury or an intrinsically unhealthy food.
IBS sometimes begins after a gastrointestinal infection. Research also examines immune signalling, the intestinal barrier and microbial activity. These findings suggest several possible pathways, not one defect shared by everyone. Mechanistic and animal studies can explain plausible processes, but cannot by themselves show that changing a particular pathway improves human symptoms.
Diagnosis is a positive clinical judgement
A positive diagnosis means identifying a characteristic pattern while checking for important alternatives. It does not mean labelling every unexplained digestive symptom as IBS. The history includes how pain relates to bowel movements, stool changes, duration, night-time symptoms, family history and possible effects of existing medicines.
NICE guidance on IBS (CG61) describes blood tests that help assess alternatives, including a full blood count, inflammatory markers and testing for coeliac disease. Depending on the presentation, clinicians may use stool tests, including faecal calprotectin to assess possible bowel inflammation. Calprotectin is not an IBS test: it answers a different diagnostic question.
Colonoscopy is not automatically necessary for every person with typical IBS symptoms. The decision depends on warning features, examination findings, screening considerations and the likelihood of other conditions. Equally, a previous IBS diagnosis does not explain every future bowel change. New findings can justify a fresh assessment.
IBS and inflammatory bowel disease are different conditions, despite their similar abbreviations. Coeliac disease, inflammatory bowel disease, bile acid diarrhoea and other problems can resemble parts of the IBS picture. Some can coexist with IBS, so finding one diagnosis does not always explain every symptom.
When the IBS explanation needs reassessment
Stop any self-directed dietary experiment that is worsening symptoms. Call 999 for sudden or severe abdominal pain, vomiting blood or collapse. Contact a GP or NHS 111 urgently for rectal bleeding, bloody diarrhoea or unexplained weight loss. NICE guidance on IBS in adults (CG61) lists warning features that need further assessment rather than an assumption of IBS, including unexplained weight loss, rectal bleeding, a family history of bowel or ovarian cancer, and, in people aged 60 or over, a change in bowel habit to looser or more frequent stools lasting more than 6 weeks. Anaemia, fever or persistent new symptoms also need GP assessment.
The age at which symptoms begin matters because the balance of possible explanations changes over a lifetime. Family history and symptoms that repeatedly wake someone from sleep can also affect assessment. These features do not establish a particular disease; they change how confidently an IBS explanation can be accepted.
Dietary management without unnecessary restriction
Regular meals and selected dietary changes feature in NICE guidance. Their purpose is to reduce symptom-provoking patterns while maintaining adequate nutrition and a workable relationship with food. Much everyday dietary guidance rests on clinical experience and limited trials, so it should not be presented as a universally proven formula.
Fibre is not a single interchangeable substance. Soluble fibre holds water and can influence stool consistency, whereas coarse insoluble fibre such as wheat bran may worsen bloating or discomfort in some people. Randomised trials support soluble fibre for overall IBS symptoms, with moderate confidence rather than a guarantee of benefit for everyone.
The low-FODMAP approach has trial evidence for symptom improvement in some adults, but studies are often short and difficult to blind. Restriction can create nutritional and social costs, especially when prolonged without support. The separate lesson, The low-FODMAP diet, properly used, explains that approach; it is not a required diet for everyone with IBS.
A food can provoke symptoms without damaging the bowel. Conversely, feeling better after excluding a food does not establish the biological reason, because several dietary factors may have changed together.
Psychological approaches and symptom-matched medicines
Gut-directed cognitive behavioural therapy and hypnotherapy aim to change responses within the gut-brain system, including symptom-related fear, attention and pain processing. They do not require symptoms to be imaginary or a person to have a psychiatric diagnosis. The intended outcomes include less symptom interference as well as reduced discomfort.
Randomised trials support benefit for some people, including those with persistent symptoms. Confidence is limited by differences between programmes, difficulty concealing which approach participants receive and unequal access to skilled practitioners. Evidence for an IBS-specific programme cannot automatically be transferred to a generic relaxation recording.
Medicines address different components of IBS. Some influence stool consistency or bowel movement, some reduce muscle spasm, and others modify pain signalling. A medicine that improves diarrhoea may leave abdominal pain unchanged. Likewise, making bowel movements more frequent does not necessarily improve bloating or overall wellbeing.
Evidence varies between medicine classes and individual outcomes. Larger placebo-controlled trials support some options for defined IBS subtypes, while evidence for several familiar options comes from smaller or older studies. People with IBS should discuss medicine decisions with their care team and should not change medicines based on a consumer device.
Who the evidence fits, and how to judge claims
Most management trials concern adults with an established IBS diagnosis. Their findings do not automatically apply to children, pregnancy, unexplained bleeding or a newly changing bowel pattern. People with substantial dietary restriction, another digestive condition or several regular medicines may also need a different assessment of benefits and burdens.
Probiotic findings are mixed because strains, combinations and study methods differ. An apparent benefit from one preparation does not validate all products carrying the same label. Microbiome differences in observational studies do not establish whether microbes cause symptoms, reflect diet or respond to altered bowel function. Commercial stool profiles cannot reliably select an individual IBS management plan.
- Check the participants: did they have diagnosed IBS and a similar bowel pattern?
- Check the comparison: was there a randomised control group, or only testimonials and before-and-after reports?
- Check the outcome: did pain, urgency or daily functioning improve, or only a laboratory marker?
- Check durability and burden: did benefits persist, and were adverse effects, withdrawals and dietary restrictions reported?
IBS naturally fluctuates, and people often begin a new approach when symptoms are particularly bad. Subsequent improvement can therefore exaggerate its apparent effect. Credible claims acknowledge this, distinguish average benefit from individual response and avoid promising one explanation for everyone. Meaningful progress concerns symptoms, nutrition and participation in life, not achieving a supposedly perfect microbiome.
This lesson is general education, not medical advice. Seek qualified advice if you have symptoms or a medical condition, are pregnant, or take regular medicines.
Related in this classroom
Related in other classrooms
The studies behind this page
- Irritable bowel syndrome in adults: diagnosis and management - NICE guideline CG61
Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.